ArticlePloS one2021

Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysis.

Calin Cainap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.